Acutaas Chemicals Q1 Results: Net profit up 70% to ₹74.9 crore
NiveshIQ
NSE: ACUTAAS · Chemicals
Acutaas Chemicals Ltd.
₹3,306.20▲ ₹8.50 (+0.26%)
Price Chart · Daily closes
1Y
6M
3M
1M
1W
1D
⚡ Intelligence Signals
5 active
🟢 Bullish Earnings Catalyst
📊 RS Laggard (5D)
🔄 Sector Sweep
⚡ Signals Aligned
📉 Pullback
NiveshIQ has detected 5 active signals on ACUTAAS. Sign up free to see what each signal means and how it affects the stock.
Unlock signals — freeExpected Move
1D / 1W / 1M range derived from news, fundamentals & technicals
1 Day
±1.8%
1 Week
±4.2%
1 Month
±9.6%
Confidence Score
Based on historical directional & magnitude accuracy for this stock
74
/ 100
About Acutaas Chemicals Ltd.
Acutaas Chemicals Limited is a leading Indian manufacturer of pharmaceutical intermediates, offering a diverse range of products for regulated and generic active pharmaceutical ingredients. The company's key revenue drivers include pharma intermediates, specialty chemicals, and commodity chemicals. With a strong presence in international markets, Acutaas Chemicals has established itself as a reliable supplier to the global pharmaceutical and chemical industries. Recent developments have seen the company reach new 52-week highs, with its stock price surging to Rs 3074.2. Acutaas Chemicals' competitive position is underpinned by its strong technical capabilities, research and development focus, and expanding global footprint. The company's growth outlook remains positive, driven by increasin
Financial Highlights
| Metric | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹717.00 Cr +112.10% | ₹1,007 Cr +40.40% | ₹1,339 Cr +32.90% |
| EBITDA Margin | 17.99% | 23.14% | 36.72% |
| Net Profit | ₹49.00 Cr 0.00% | ₹161.00 Cr +228.60% | ₹356.28 Cr +121.30% |
| EPS | ₹5.84 | ₹19.39 | ₹43.51 |
Annual figures in Indian Rupees (Crores). Source: BSE filings.
Recent News
Buy Acutaas Chemicals Ltd For Target Rs.3,790 - Prabhudas Liladhar Capital Ltd
Acutaas Chemicals Ltd is Rated Buy by MarketsMOJO
🔒
+ 3 more stories about Acutaas Chemicals Ltd.
Full news feed with AI impact summaries, synced in real time.
Sign up free — it's instantStrategic Outlook
- Q4FY26 results: revenue ₹433 Cr, PAT ₹134 Cr, EPS ₹16.09, EBITDA margin 45.0%. Growth context: revenue QoQ +10.1%, PAT QoQ +24.4%. Street verdict: beat, revenue surprise +2.4%, PAT surprise +9.8%.
Realisations, demand recovery, cost efficiency, capacity utilisation, and margin discipline remain the key forward drive...
FY26 (last completed FY): revenue ₹1, 339 Cr, PAT ₹356 Cr, EBITDA margin 36.7%, EPS ₹43.51. Year-on-year: revenue YoY +3...
🔒
+ 3 more outlook points
Growth drivers, key risks, and upcoming catalysts — unlocked free.
Sign up free — it's instantEverything you unlock with a free account
⚡Intelligence Signals — AI-detected patterns across news, earnings & technicals
📈Price Chart — 1D to 1Y daily closes for ACUTAAS
🎯Expected Move — 1D / 1W / 1M range from news, fundamentals & technicals
🧠Confidence Score — Historical directional & magnitude accuracy for this stock
🎙Analyst Target Price — Consensus target with buy / hold / sell breakdown
📰Full News Feed — All stories synced in real time with AI impact summaries
🔭Strategic Outlook — Growth drivers, risks & upcoming catalysts
📊Watchlist & Portfolio — Track ACUTAAS alongside your other holdings
Unlock full ACUTAAS research — free
No credit card · No trial · Always free to start
Frequently Asked Questions
What AI signals does NiveshIQ provide for Acutaas Chemicals Ltd.?
NiveshIQ detects active intelligence signals for Acutaas Chemicals Ltd. (ACUTAAS) — including earnings catalysts, relative strength patterns, sector sweeps, and pullback setups. It also shows an Expected Move (1D/1W/1M range based on news, fundamentals and technicals) and a Confidence Score based on historical directional and magnitude accuracy. These are exclusive to NiveshIQ.
What are the key financials for Acutaas Chemicals Ltd.?
Acutaas Chemicals Ltd. operates in the Chemicals sector with a market capitalisation of ₹2,706,822.9L Cr. Revenue, net profit, EPS and EBITDA margins across the last three annual periods are shown above, sourced from BSE filings.
Does NiveshIQ provide investment advice?
No. NiveshIQ provides educational market intelligence and research context, not investment advice or buy/sell recommendations.